Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Checkpoint Inhibitors and Carbon iON Radiotherapy In Solid Cancers With Stable Disease

NCT05229614 is registered in ClinicalTrials.gov with CNAO National Center of Oncological Hadrontherapy as lead sponsor.

NCT NCT05229614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05229614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Checkpoint Inhibitors and Carbon iON Radiotherapy In Solid Cancers With Stable Disease
Lead sponsor
CNAO National Center of Oncological Hadrontherapy
Phase
Phase 2
Overall status
Recruiting
Start date
July 26, 2022
Completion date
August 31, 2026
Enrollment
27 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, melanoma, non small cell lung cancer, urothelial carcinoma